International Journal of Molecular Sciences · 2022 · 23 citations · 48 references
MedicineNeurosciencePharmacologyCancer PharmacologyChemotherapyNeuro-oncologyAxonal DegenerationIntracellular Calcium SignalingIon Channel ToxicityNeuroprotectionNeurotoxic MechanismsNeurotoxicity MechanismsCentral Neural HyperexcitabilityNeurotoxicityOrganotypic CultureOrganotypic Culture ModelsSodium Calcium ExchangersSodium Channel DysregulationVoltage-gated ChannelsVoltage-gated Sodium Channels
Oxaliplatin (OHP)-induced peripheral neurotoxicity (OIPN) is a frequent adverse event of colorectal cancer treatment. OIPN encompasses a chronic and an acute syndrome. The latter consists of transient axonal hyperexcitability, due to unbalance in Na+ voltage-operated channels (Na+VOC). This leads to sustained depolarisation which can activate the reverse mode of the Na+/Ca2+ exchanger 2 (NCX2), resulting in toxic Ca2+ accumulation and axonal damage (ADa). We explored the role of NCX2 in in vitro and in vivo settings. Embryonic rat Dorsal Root Ganglia (DRG) organotypic cultures treated with SEA0400 (SEA), a NCX inhibitor, were used to assess neuroprotection in a proof-of-concept and pilot study to exploit NCX modulation to prevent ADa. In vivo, OHP treated mice (7 mg/Kg, i.v., once a week for 8 weeks) were compared with a vehicle-treated group (n = 12 each). Neurophysiological and behavioural testing were performed to characterise acute and chronic OIPN, and morphological analyses were performed to detect ADa. Immunohistochemistry, immunofluorescence, and western blotting (WB) analyses were also performed to demonstrate changes in NCX2 immunoreactivity and protein expression. In vitro, NCX inhibition was matched by ADa mitigation. In the in vivo part, after verifyingboth acute and chronic OIPN had ensued, we confirmed via immunohistochemistry, immunofluorescence, and WB that a significant NCX2 alteration had ensued in the OHP group. Our data suggest NCX2 involvement in ADa development, paving the way to a new line of research to prevent OIPN.
48
Postsynaptic Calcium Is Sufficient for Potentiation of Hippocampal Synaptic Transmission
Robert C. Malenka, Julie A. Kauer, Robert S. Zucker et al. · Science · 1988 · 833 citations
Clinical pharmacokinetics of oxaliplatin: a critical review.
Martin A. Graham, G. Lockwood, Dennis Greenslade et al. · PubMed · 2000 · 461 citations
Naohisa Arakawa, Kazuhiro Takuma, Yoko Kishida et al. · Journal of Pharmacology and Experimental Therapeutics · 2001 · 345 citations
Medicine, Neuroscience, Pharmacology +13